Mitogen-activated protein kinase p38α and retinal ischemic preconditioning

Experimental Eye Research

Volumn 89, Issue 5, 2009, Pages 782-790

  Dreixler, John C ^a   Barone, Frank C ^b   Shaikh, Afzhal R ^a   Du, Eugenie ^a   Roth, Steven ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

ischemic preconditioning; p38; retinal ischemia

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR ANTAGONIST; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANISOMYCIN; DIAZOXIDE; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RETINA ISCHEMIA; RNA INTERFERENCE;

ANIMALS; ANISOMYCIN; DIAZOXIDE; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ENZYME ACTIVATORS; IMIDAZOLES; INTRAOCULAR PRESSURE; ISCHEMIA; ISCHEMIC PRECONDITIONING; MITOGEN-ACTIVATED PROTEIN KINASE 14; PHOSPHORYLATION; POTASSIUM CHANNELS; PROTEIN KINASE INHIBITORS; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; REPERFUSION INJURY; RETINAL NEURONS; RETINAL VESSELS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 70349605991     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.07.006     Document Type: Article

References (31)

1. Aakalu G., Smith W.B., Nguyen N., Jiang C., and Schuman E.M. Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron 30 (2001) 489-502
2. Barea-Rodriguez E.J., Rivera D.T., Jaffe D.B., and Martinez Jr. J.L. Protein synthesis inhibition blocks the induction of mossy fiber long-term potentiation in vivo. J. Neurosci. 20 (2000) 8528-8532
3. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
4. Cross T.G., Scheel-Toellner D., Henriquez N.K., Deacon E., Salmon M., and Lord J.M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res. 256 (2000) 34-41
5. Dreixler J.C., Hagevik S., Hemmert J.W., Shaikh A.R., Rosenbaum D.M., and Roth S. Involvement of erythropoietin in retinal ischemic preconditioning. Anesthesiology 110 (2009) 774-780
6. Dreixler J.C., Hemmert J.W., Shenoy S.K., Shen Y., Lee H.T., Shaikh A.R., Rosenbaum D.M., and Roth S. The role of Akt/protein kinase B subtypes in retinal ischemic preconditioning. Exp. Eye Res. 88 (2009) 512-521
7. Dreixler J.C., Shaikh A.R., Shenoy S.K., Shen Y., and Roth S. Protein kinase C subtypes and retinal ischemic preconditioning. Exp. Eye Res. 87 (2008) 300-311
8. Farh K.K., Grimson A., Jan C., Lewis B.P., Johnston W.K., Lim L.P., Burge C.B., and Bartel D.P. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310 (2005) 1817-1821
9. Gidday J. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 7 (2006) 437-448
10. Hornung V., Guenthner-Biller M., Bourquin C., Ablasser A., Schlee M., Uematsu S., Noronha A., Manoharan M., Akira S., de Fougerolles A., Endres S., and Hartmann G. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11 (2005) 263-270
11. Huesken D., Lange J., Mickanin C., Weiler J., Asselbergs F., Warner J., Meloon B., Engel S., Rosenberg A., Cohen D., Labow M., Reinhardt M., Natt F., and Hall J. Design of a genome-wide siRNA library using an artificial neural network. Nat. Biotechnol. 23 (2005) 995-1001
12. Irving E.A., and Bamford M. Role of mitogen- and stress-activated kinases in ischemic injury. J. Cereb. Blood Flow Metab. 22 (2002) 631-647
13. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., and MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
14. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., and Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U S A 99 (2002) 10659-10664
15. Kikuchi M., Tenneti L., and Lipton S.A. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J. Neurosci. 20 (2000) 5037-5044
16. Kumar S., Boehm J., and Lee J. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug. Discov. 2 (2003) 717-726
17. Lee J.C., Kumar S., Griswold D.E., Underwood D.C., Votta B.J., and Adams J.L. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 47 (2000) 185-201
18. Li B., Jennings N.M., Rosenbaum P.S., Maxwell K.M., and Roth S. Differential roles of adenosine receptor subtypes in retinal ischemia-reperfusion injury in the rat. Exp. Eye Res. 68 (1999) 9-17
19. Li B., and Roth S. Retinal ischemic preconditioning in the rat: requirement for adenosine and repetitive induction. Invest. Ophthalmol. Vis. Sci. 40 (1999) 1200-1216
20. Li B., Yang C., Rosenbaum D.M., and Roth S. Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp. Eye Res. 70 (2000) 755-765
21. Li Y., Roth S., Laser M., Ma J.X., and Crosson C.E. Retinal preconditioning and the induction of heat-shock protein 27. Invest. Ophthalmol. Vis. Sci. 44 (2003) 1299-1304
22. McLaughlin B., Hartnett K.A., Erhardt J.A., Legos J.J., White R.F., Barone F.C., and Aizenman E. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc. Natl. Acad. Sci. U S A 100 (2003) 715-720
23. Ping P., Zhang J., Cao X., Li R.C., Kong D., Tang X.L., Qiu Y., Manchikalapudi S., Auchampach J.A., Black R.G., and Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am. J. Physiol. 276 (1999) H1468-1481
24. Roth S., Dreixler J.C., Shaikh A.R., Lee K.H., and Bindokas V. Mitochondrial potassium ATP channels and retinal ischemic preconditioning. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2114-2124
25. Roth S., Li B., Rosenbaum P.S., Gupta H., Goldstein I.M., Maxwell K.M., and Gidday J.M. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest. Ophthalmol. Vis. Sci. 39 (1998) 775-785
26. Roth S., Shaikh A.R., Hennelly M.M., Li Q., Bindokas V., and Graham C.E. Mitogen-activated protein kinases and retinal ischemia. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5383-5395
27. Singh M., Savitz S.I., Hoque R., Rosenbaum P.S., Roth S., and Rosenbaum D.M. Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J. Neurochem. 77 (2001) 466-475
28. Tanaka H., Yokota H., Jover T., Cappuccio I., Calderone A., Simionescu M., Bennett M.V., and Zukin R.S. Ischemic preconditioning: neuronal survival in the face of caspase-3 activation. J. Neurosci. 24 (2004) 2750-2759
29. Tanaka K. Alteration of second messengers during acute cerebral ischemia-adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein. Prog. Neurobiol. 65 (2001) 173-207
30. Whitlock N.A., Agarwal N., Ma J.-X., and Crosson C.E. Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1092-1098
31. Zhang C., Rosenbaum D.M., Shaikh A.R., Q L., Rosenbaum P.S., Pelham D.J., and Roth S. Ischemic preconditioning attenuates apoptosis following retinal ischemia in rats. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3059-3066